Information Provided By:
Fly News Breaks for December 24, 2019
Dec 24, 2019 | 07:50 EDT
Credit Suisse analyst Martin Auster lowered his price target for Sarepta (SRPT) to $185 from $190, while reiterating an Outperform rating on the shares after the company announced SRP-9001 ex-U.S. commercial partnership with Roche (RHHBY). The analyst believes Sarepta's deal with Roche provides validation and avoidance of meaningful dilution but reduces ceiling.
News For SRPT;RHHBY From the Last 2 Days
There are no results for your query SRPT;RHHBY